🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ying Pang

Shanghai East Hospital

ORCID: 0000-0001-6195-2150
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

(2023)10.1158/1078-0432.c.6530789
Top 100%
0DataRank
Top 100%0 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Papers

Driven by 19 papers — median percentile 0. Top paper: “Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma”.

Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma

Cancers(2020)10.3390/cancers12020280
N/A
1.1DataRank · unranked
43 citations

Ying Pang, Veronika Caisová, Jianyi Ding, Di Yu, Yiqiang Zhou +5 more

Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4730
N/A
0.617DataRank · unranked
60 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Tumor mutational burden and immunotherapy in gliomas

Trends in cancer(2021)10.1016/j.trecan.2021.08.005
N/A
0.606DataRank · unranked
56 citations

Alice Ranjan, Ying Pang, Guangyang Yu, Olga Kim, Javed Khan +2 more

Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas

Cancers(2021)10.3390/cancers13236092
N/A
0.533DataRank · unranked
34 citations

Ying Pang, Mythili Merchant, Chimene Kesserwan, Vineela Gangalapudi, Abdalla Abdelmaksoud +15 more

Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiency

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad102
N/A
0.425DataRank · unranked
16 citations

Madison Butler, Zach Sergi, Robert W. Robey, Meili Zhang, Raj Chari +20 more

Neuraxial dysraphism in EPAS1- associated syndrome due to improper mesenchymal transition

Neurology Genetics(2020)10.1212/nxg.0000000000000414
N/A
0.416DataRank · unranked
15 citations

Anthony J. Cappadona, Davis P. Argersinger, Ying Pang, Herui Wang, Matthew A. Nazari +11 more

Report of Canonical BCR-ABL1 Fusion in Glioblastoma

JCO Precision Oncology(2021)10.1200/po.20.00519
N/A
0.330DataRank · unranked
8 citations

Guangyang Yu, Madison Butler, Sivasish Sindiri, Young K. Song, Jun S. Wei +24 more

Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in PMS2

Frontiers in Oncology(2022)10.3389/fonc.2022.954879
N/A
0.269DataRank · unranked
5 citations

Margarita Raygada, Ying Pang, Martha Quezado, Mark Raffeld, Liqiang Xi +14 more

Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib

iScience(2025)10.1016/j.isci.2025.112283
N/A
0.240DataRank · unranked
3 citations

Li Qi, Zach Sergi, Guangyang Yu, Olga Kim, Peng Lu +20 more

Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy

Frontiers in Oncology(2021)10.3389/fonc.2020.601452
N/A
0.165DataRank · unranked
2 citations

Madison Butler, Abdalla Abdelmaksoud, Ying Pang, Yuting Su, Zachary Rae +21 more

Targeting CDK9 for the Treatment of Glioblastoma

Cancers(2021)10.3390/cancers13123039
N/A
0DataRank · unranked
28 citations

Ying Pang, Madison Butler, Mythili Merchant, Olga Kim, Guangyang Yu +5 more

Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas

The Journal of Pathology(2020)10.1002/path.5472
N/A
0DataRank · unranked
42 citations

Catleen Conrad, Sascha Brückmann, Ying Pang, Eduardo Caleiras, Masanori Murakami +21 more

Flap endonuclease 1 and DNA-PKcs synergistically participate in stabilizing replication fork to encounter replication stress in glioma cells

Journal of Experimental & Clinical Cancer Research(2022)10.1186/s13046-022-02334-0
N/A
0DataRank · unranked
13 citations

Mu Chen, Ying Pang, Meng Cheng, Bingsong Huang, Siyi Xu +4 more

Therapeutic Targeting of SDHB -Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2335
N/A
0DataRank · unranked
44 citations

Ying Pang, Boqun Zhu, Ondřej Uher, Veronika Caisová, Thanh‐Truc Huynh +8 more

C-Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain-of-Function Mutations in HIF2A: Clinical Evidence for EPO Regulating FGF23

Journal of Bone and Mineral Research(2020)10.1002/jbmr.4195
N/A
0DataRank · unranked
14 citations

Sydney M Brown, Ying Pang, Thanh Huynh, Zhengping Zhuang, Karel Pacák +2 more

Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

(2023)10.1158/1078-0432.c.6530789
Top 100%
0DataRank
Top 100%0 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

(2023)10.1158/1078-0432.c.6530789.v1
Top 100%
0DataRank
Top 100%0 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab158
N/A
0DataRank · unranked
35 citations

Ying Pang, Linda Krobova, Michal Kraus, Zuzana Nahácka, Štěpána Boukalová +23 more

MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa065
N/A
0DataRank · unranked
29 citations

Madison Butler, Meili Zhang, Wei Zhang, Hua Song, Lee Hwang +15 more